Dr. Callander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-266-6020- Is this information wrong?
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
- NYU Grossman School of MedicineResidency, Internal Medicine, 1985 - 1988
- Tufts University School of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1988 - Present
- WI State Medical License 2004 - 2025
- TX State Medical License 1995 - 2024
- GA State Medical License 1989 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma Start of enrollment: 2006 Nov 01
- Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma Start of enrollment: 2004 Feb 01
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2008 Feb 29
- Join now to see all
Publications & Presentations
PubMed
- Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.Attaya Suvannasankha, Nizar Bahlis, Suzanne Trudel, Katja Weisel, Christian Koenecke, Albert Oriol, Peter M Voorhees, Aranzazu A Alonso, Natalie S Callander, María-Vic...> ;Cancer. 2024 Apr 17
- 1 citationsUpdate on the current and future use of CAR-T to treat multiple myeloma.Zhubin Gahvari, Matthew Brunner, Timothy Schmidt, Natalie S Callander> ;European Journal of Haematology. 2024 Apr 1
- SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma.Timothy Schmidt, Zhubin Gahvari, Natalie S Callander> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 16
- Join now to see all
Abstracts/Posters
- Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)Natalie Scott Callander, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid LeukemiaNatalie Scott Callander, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase 1b/2 Study of Selinexor, Carfilzomib, and Dexamethasone (SKd) in Relapsed/ Refractory Multiple Myeloma (RRMM)Natalie Scott Callander, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- COVID mRNA Vaccine Equally Safe for People with CancerFebruary 7th, 2022
- COVID-19 Vaccines Are Safe for People with Cancer, Researchers SayFebruary 7th, 2022
- Multiple Myeloma: Choosing Your PathDecember 18th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- University HospitalMadison, Wisconsin
- William S. Middleton Memorial Veterans' HospitalMadison, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: